vs
IMMUCELL CORP（ICCC）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Rocky Mountain Chocolate Factory, Inc.的季度营收约是IMMUCELL CORP的1.4倍（$7.5M vs $5.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -2.5%，领先0.5%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -8.4%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-1.8M），过去两年IMMUCELL CORP的营收复合增速更高（3.9% vs 1.9%）
ImmuCell Corp是一家总部位于美国的动物健康生物技术企业，主要研发、生产和销售以奶牛为主的家畜相关保健与治疗产品，核心产品包括乳腺炎等常见牛类疾病的防治方案，主要服务北美地区的畜牧养殖户和兽医机构。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
ICCC vs RMCF — 直观对比
营收规模更大
RMCF
是对方的1.4倍
$5.5M
营收增速更快
RMCF
高出4.0%
-8.4%
净利率更高
RMCF
高出0.5%
-2.5%
自由现金流更多
RMCF
多$498.5K
$-1.8M
两年增速更快
ICCC
近两年复合增速
1.9%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.5M | $7.5M |
| 净利润 | $-139.7K | $-155.0K |
| 毛利率 | 42.9% | 34.0% |
| 营业利润率 | 0.4% | 1.1% |
| 净利率 | -2.5% | -2.1% |
| 营收同比 | -8.4% | -4.4% |
| 净利润同比 | 80.1% | 81.7% |
| 每股收益（稀释后） | $-0.02 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICCCRMCF
| Q4 25 | — | $7.5M | ||
| Q3 25 | $5.5M | $6.8M | ||
| Q2 25 | $6.4M | $6.4M | ||
| Q1 25 | $8.1M | $8.9M | ||
| Q4 24 | $7.8M | $7.9M | ||
| Q3 24 | $6.0M | $6.4M | ||
| Q2 24 | $5.5M | $6.4M | ||
| Q1 24 | $7.3M | $7.3M |
净利润ICCCRMCF
| Q4 25 | — | $-155.0K | ||
| Q3 25 | $-139.7K | $-662.0K | ||
| Q2 25 | $501.9K | $-324.0K | ||
| Q1 25 | $1.4M | $-2.9M | ||
| Q4 24 | — | $-847.0K | ||
| Q3 24 | $-701.7K | $-722.0K | ||
| Q2 24 | $-1.5M | $-1.7M | ||
| Q1 24 | $-437.9K | $-1.6M |
毛利率ICCCRMCF
| Q4 25 | — | 34.0% | ||
| Q3 25 | 42.9% | 23.6% | ||
| Q2 25 | 43.7% | 31.1% | ||
| Q1 25 | 41.6% | 10.8% | ||
| Q4 24 | 36.5% | 23.4% | ||
| Q3 24 | 26.3% | 31.8% | ||
| Q2 24 | 22.5% | 12.8% | ||
| Q1 24 | 31.6% | 24.3% |
营业利润率ICCCRMCF
| Q4 25 | — | 1.1% | ||
| Q3 25 | 0.4% | -7.0% | ||
| Q2 25 | 8.8% | -2.3% | ||
| Q1 25 | 13.9% | -30.3% | ||
| Q4 24 | 8.0% | -8.9% | ||
| Q3 24 | -9.6% | -14.3% | ||
| Q2 24 | -25.3% | -25.4% | ||
| Q1 24 | -4.1% | -21.7% |
净利率ICCCRMCF
| Q4 25 | — | -2.1% | ||
| Q3 25 | -2.5% | -9.7% | ||
| Q2 25 | 7.8% | -5.1% | ||
| Q1 25 | 17.9% | -32.5% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | -11.7% | -11.3% | ||
| Q2 24 | -28.0% | -25.9% | ||
| Q1 24 | -6.0% | -21.9% |
每股收益（稀释后）ICCCRMCF
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.02 | $-0.09 | ||
| Q2 25 | $0.06 | $-0.04 | ||
| Q1 25 | $0.16 | $-0.38 | ||
| Q4 24 | $0.09 | $-0.11 | ||
| Q3 24 | $-0.09 | $-0.11 | ||
| Q2 24 | $-0.20 | $-0.26 | ||
| Q1 24 | $-0.06 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.9M | $641.0K |
| 总债务越低越好 | $9.5M | — |
| 股东权益账面价值 | $29.8M | $6.0M |
| 总资产 | $45.7M | $20.7M |
| 负债/权益比越低杠杆越低 | 0.32× | — |
8季度趋势，按日历期对齐
现金及短期投资ICCCRMCF
| Q4 25 | — | $641.0K | ||
| Q3 25 | $3.9M | $2.0M | ||
| Q2 25 | — | $893.0K | ||
| Q1 25 | — | $720.0K | ||
| Q4 24 | $3.8M | $1.1M | ||
| Q3 24 | — | $973.0K | ||
| Q2 24 | $1.3M | $637.0K | ||
| Q1 24 | $960.3K | $2.1M |
总债务ICCCRMCF
| Q4 25 | — | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $8.7M | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $10.2M | — |
股东权益ICCCRMCF
| Q4 25 | — | $6.0M | ||
| Q3 25 | $29.8M | $6.1M | ||
| Q2 25 | $29.9M | $6.7M | ||
| Q1 25 | $29.0M | $7.0M | ||
| Q4 24 | $27.5M | $9.8M | ||
| Q3 24 | $26.4M | $10.5M | ||
| Q2 24 | $23.5M | $9.0M | ||
| Q1 24 | $24.6M | $10.6M |
总资产ICCCRMCF
| Q4 25 | — | $20.7M | ||
| Q3 25 | $45.7M | $22.3M | ||
| Q2 25 | $46.7M | $20.1M | ||
| Q1 25 | $45.6M | $21.2M | ||
| Q4 24 | $45.1M | $21.6M | ||
| Q3 24 | $44.4M | $21.1M | ||
| Q2 24 | $41.9M | $19.0M | ||
| Q1 24 | $43.1M | $20.6M |
负债/权益比ICCCRMCF
| Q4 25 | — | — | ||
| Q3 25 | 0.32× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.42× | — | ||
| Q1 24 | 0.41× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-1.3M |
| 自由现金流率自由现金流/营收 | -32.3% | -16.9% |
| 资本支出强度资本支出/营收 | 10.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $715.4K | — |
8季度趋势，按日历期对齐
经营现金流ICCCRMCF
| Q4 25 | — | $-1.2M | ||
| Q3 25 | $-1.2M | $-488.0K | ||
| Q2 25 | $1.6M | $350.0K | ||
| Q1 25 | $1.6M | $1.2M | ||
| Q4 24 | $-3.1K | $-2.1M | ||
| Q3 24 | $-639.3K | $-3.5M | ||
| Q2 24 | $581.8K | $-2.2M | ||
| Q1 24 | $418.5K | $129.0K |
自由现金流ICCCRMCF
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-1.8M | $-544.0K | ||
| Q2 25 | $1.4M | $182.0K | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $-199.3K | — | ||
| Q3 24 | $-727.7K | $-4.6M | ||
| Q2 24 | $471.0K | $-2.6M | ||
| Q1 24 | $348.1K | $-352.3K |
自由现金流率ICCCRMCF
| Q4 25 | — | -16.9% | ||
| Q3 25 | -32.3% | -8.0% | ||
| Q2 25 | 22.4% | 2.9% | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | -2.6% | — | ||
| Q3 24 | -12.1% | -72.6% | ||
| Q2 24 | 8.6% | -40.2% | ||
| Q1 24 | 4.8% | -4.9% |
资本支出强度ICCCRMCF
| Q4 25 | — | 0.5% | ||
| Q3 25 | 10.8% | 0.8% | ||
| Q2 25 | 2.4% | 2.6% | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 1.5% | 17.5% | ||
| Q2 24 | 2.0% | 6.5% | ||
| Q1 24 | 1.0% | 6.6% |
现金转化率ICCCRMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.19× | — | ||
| Q1 25 | 1.09× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICCC
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
